课题基金 / 基金详情

HRV Biofeedback in Pain Patients: Pilot Intervention for Pain, Fatigue & Sleep

HRV Biofeedback in Pain Patients: Pilot Intervention for Pain, Fatigue & Sleep
疼痛患者的 HRV 生物反馈:针对疼痛、疲劳的试点干预
批准号:
8924639
负责人:
James Burch
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2019-06-30

项目摘要

项目成果

James Burch的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Scientific literature provides evidence for the importance of behavioral treatments for chronic pain patients. Pain is one of the most common reasons for seeking care among Veterans of all wars, and among all Veterans, chronic, non-malignant neuromusculoskeletal pain is the most commonly diagnosed medical problem. Many Veterans in chronic pain use avoidance strategies to dampen the intensity of pain, as is often seen in social behaviors and movement. Although the VA stresses the interdisciplinary approach to pain management, standard therapy for chronic pain still relies heavily on the use of opioids. Thus, an effective non-pharmacological pain therapy that reduces the effects of pain and the usage of opioid medications would be a significant benefit to all chronic pain patients. Heart Rate Variability Biofeedback is a complementary, non-pharmacological technique for improvement autonomic function that we propose in this study will reduce pain ratings and improve sleep, activity, cognition, and quality of life for Veteran pain patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk
  • 批准号:
    10408495
  • 项目类别:
  • 资助金额:
    $51.88万
  • 财政年份:
    2019
  • 负责人:
    James Burch
  • 依托单位:
Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk
Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk
Role of Circadian Factors in Inflammation and Colorectal Adenoma Risk
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: